A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis

This is a three-year study in subjects with axillary hyperhidrosis involving injection of Botulinum Toxin Type A into the axilla to reduce sweating.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hyperhidrosis Skin Diseases Skin and Connective Tissue Diseases Sweat Gland Diseases

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Marked axillary hyperhidrosis

Exclusion criteria

Previous use of botulinum toxin for hyperhidrosis

Treatment and study plan

Botulinum Toxin Type A

Drug

Primary outcomes

Subject's assessment of the severity of hyperhidrosis

Secondary outcomes

Measurement of axillary sweat production

Sponsors and collaborators

Lead sponsor

Allergan

Industry

Registry information

Important dates

Study start: 2002
Primary completion: 2005
Study completion: 2005
First posted: Sep 15, 2005
Registry last updated: May 30, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed